Compound Summary
Compound Name: | agmatine |
Compound CID: | 199 |
Synonyms: | agmatine 1-(4-Aminobutyl)guanidine 306-60-5 (4-Aminobutyl)guanidine Argmatine More... |
Iupac Name: | 2-(4-aminobutyl)guanidine |
InChI: | InChI=1S/C5H14N4/c6-3-1-2-4-9-5(7)8/h1-4,6H2,(H4,7,8,9) |
InChIKey: | QYPPJABKJHAVHS-UHFFFAOYSA-N |
Canonical Smiles: | C(CCN=C(N)N)CN |
Isomeric Smiles: | C(CCN=C(N)N)CN |
Molecular Weight: | 130.19 |
Molecular Formula: | C5H14N4 |
Molecular Weight: | 130.19 |
Molecular Formula: | C5H14N4 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 9 |
Complexity: | 85 |
agmatine | agmatine |
---|---|
agmatine |
1-(4-Aminobutyl)guanidine |
306-60-5 |
(4-Aminobutyl)guanidine |
Argmatine |
1-Amino-4-guanidobutane |
guanidine, (4-aminobutyl)- |
N-4-Aminobutylguanidine |
N-(4-aminobutyl)guanidine |
2-(4-aminobutyl)guanidine |
(4-Aminobutyl) guanidine |
1,4-Butanediamine, N-(aminoiminomethyl)- |
UNII-70J407ZL5Q |
4-Guanidino-1-butanamine |
CHEMBL58343 |
CHEBI:17431 |
70J407ZL5Q |
agmatinium |
Guanidine, (4-aminobutyl)- (8CI)(9CI) |
AGMATINE SULFATE ENDOGENOUS AGONIST AT |
AG2 |
EINECS 206-187-7 |
NSC 56332 |
1-Amino-4-guanidinobutane |
.Agmatin |
Spectrum_001656 |
Tocris-0842 |
SpecPlus_000500 |
Spectrum2_001608 |
Spectrum4_001905 |
Spectrum5_000590 |
Lopac-A-7127 |
(4-aminobutyl)-Guanidine |
bmse000063 |
bmse000812 |
bmse000936 |
1, N-(aminoiminomethyl)- |
Lopac0_000060 |
SCHEMBL19647 |
US8633208, Agmatine |
KBioGR_002496 |
KBioGR_002550 |
KBioSS_002136 |
KBioSS_002559 |
Agmatine sulfate, 90.0%+ |
DivK1c_006596 |
SPBio_001615 |
CS-WAA0304 |
GTPL4127 |
DTXSID0040961 |
BDBM85213 |
KBio1_001540 |
KBio2_002136 |
KBio2_002550 |
KBio2_004704 |
KBio2_005118 |
KBio2_007272 |
KBio2_007686 |
KBio3_003028 |
NSC_199 |
cMAP_000079 |
NSC56332 |
ZINC1532560 |
NSC-56332 |
AKOS006230062 |
AKOS015894488 |
CCG-204155 |
DB08838 |
SDCCGMLS-0066765.P001 |
SDCCGSBI-0050048.P003 |
N-(aminoiminomethyl)-1,4-Butanediamine |
NCGC00015083-01 |
NCGC00015083-02 |
NCGC00015083-03 |
NCGC00015083-04 |
NCGC00015083-05 |
NCGC00015083-06 |
NCGC00015083-10 |
NCGC00024820-01 |
NCGC00024820-02 |
NCGC00024820-03 |
NCGC00024820-04 |
CAS_306-60-5 |
DB-068320 |
FT-0693017 |
A-4000 |
A-4001 |
C00179 |
21782-EP2314571A2 |
Q394317 |
C4D19DE1-F243-434B-9E72-720B42C5AD40 |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 1.000000000000000 | mM | 16.000000000000000 | S | N2 | 25643626 | Active | ||||||
Caenorhabditis elegans | 1.000000000000000 | mM | 10.000000000000000 | S | N2 | 25643626 | Active | ||||||
Caenorhabditis elegans | 0.100000000000000 | mM | 1.000000000000000 | NS | N2 | 25643626 | Inactive | ||||||
Caenorhabditis elegans | 10.000000000000000 | mM | -13.000000000000000 | S | N2 | 25643626 | Inactive | ||||||
Caenorhabditis elegans | 10.000000000000000 | mM | -20.000000000000000 | S | N2 | 25643626 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 16.000000000000000 | 1 | 5 |